A phase 1b multicenter, open-label study of investigational TAK-228 (MLN0128) plus TAK-117 (MLN1117) in adult patients with advanced nonhematologic malignancies. (December 2016) - Juric, D.; Lopez, J.; Rasco, D.; Macarulla Mercadé, T.; Xu, Q.; Brittany, B.; Kuida, K.; Patel, C.; Neuwirth, R.; Enke, A.; Zohren, F.; Burris, H.A.